Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Nvidia plans to invest $1 billion over five years to advance “super intelligence” research in the United States, focusing on quantum computing, healthcare, and energy security.

Nvidia plans to invest $1 billion over five years to advance “super intelligence” research in the United States, focusing on quantum computing, healthcare, and energy security.

华尔街见闻华尔街见闻2026/10/08 15:31
Show original

This investment will be implemented through three pathways: supporting American universities in acquiring computational infrastructure; increasing investment in the field of quantum computing in the United States; and supporting cloud service providers that meet the mission needs of the U.S. government. Jensen Huang stated that this investment will place superintelligent capabilities into the hands of American scientists, "This is the path for the United States to turn scientific leadership into industrial leadership and innovation into employment opportunities."

NVIDIA has announced an investment of $1 billion in resources for the U.S. scientific research sector over the next five years, with a focus on quantum computing, healthcare, and energy security—areas critical to the United States' strategic standing. The company aims to further deepen its collaborations among industry, academia, and the U.S. government.

This pledge was officially unveiled at the "Science: The New Golden Age" event held in Washington, attended by U.S. officials, industry leaders, and representatives from the scientific community.

The White House Office of Science and Technology Policy (OSTP) announced an expansion of the "Genesis Mission" at the event. As a key industry partner of this program, NVIDIA immediately announced the above-mentioned investment commitment.

Jensen Huang, founder and CEO of NVIDIA, stated that the $1 billion investment will put advanced superintelligence capabilities into the hands of American scientists, aiming to accelerate breakthroughs in medicine, energy, and materials. "This is the path by which America converts scientific leadership into industrial leadership, and transforms innovation into job opportunities."

Investments Cover Universities, Quantum Computing, and Government Cloud Services

According to NVIDIA’s specific plans, this $1 billion commitment will be implemented over five years through three channels:

Supporting U.S. higher education and research institutions with access to computing power and superintelligent infrastructure; increasing investment in U.S. leadership in quantum computing; and supporting cloud service providers that serve U.S. government mission requirements.

NVIDIA also announced that it will participate as a partner in several phase two "Genesis Mission" projects, covering quantum computing, nuclear fusion, accelerator design, and microelectronics.

More Than 20 Years of Collaboration with U.S. National Laboratories

NVIDIA’s partnership with U.S. national laboratories has spanned more than two decades.

Last year, the company announced a collaboration with the U.S. Department of Energy (DOE) under the "Genesis Mission" framework. One core project is building the DOE’s largest scientific research supercomputer at Argonne National Laboratory.

In addition, NVIDIA has also supported Argonne and Los Alamos National Laboratories with seven new systems, further strengthening the DOE’s core mission to drive technological leadership.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

US Stock Movement | SuperX AI Technology (SUPX.US) once fell more than 2.5%, hitting an intraday low of $6.46

SuperX AI Technology's stock price declined, falling more than 2.5% at one point.

智通财经•2026/10/08 16:11

BUZZ-Pacira BioSciences participated in a Viatris acquisition deal worth 1.65 billions dollars

Latest Update October 8 – Pacira BioSciences (PCRX.O) shares surged by 44%, hitting a more than three-year high at $36.30. If the rally holds, PCRX is poised for its largest single-day gain on record. Pharmaceutical company Viatris (VTRS.O) will acquire Pacira BioSciences in a $1.65 billion cash deal, offering $36.50 per share. The offer represents a premium of approximately 44.8% over Pacira’s recent closing price of $25.20. The transaction will add Pacira’s non-opioid pain medications Exparel and Zilretta to Viatris' product portfolio. Viatris shares fell 2.6% to $17.04. JPMorgan stated: “We believe this acquisition will not significantly alter VTRS' overall financial profile in the short or long term, and expect Exparel’s sales to gradually decline post-2030 due to generic market entry.” Both parties expect to complete the transaction by the end of 2026. Including intraday fluctuations, PCRX shares have risen 40.2% year-to-date, while VTRS has gained 36.8%. (For the convenience of non-English speakers, Reuters provides automated translations of its reports into several other languages. As automated translation may contain errors or lack the necessary context, Reuters does not guarantee the accuracy of automated translated texts and provides them for readers’ convenience only. Reuters assumes no liability for any damage or losses resulting from the use of automated translation.)

路透社•2026/10/08 16:11